Meagan Ellinger, PHARMD | |
2030 Hetrick Rd, Bath, IN 47010-9705 | |
(765) 580-9118 | |
Not Available |
Full Name | Meagan Ellinger |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 2030 Hetrick Rd, Bath, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982256657 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 26028183A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Meagan Ellinger, PHARMD 2030 Hetrick Rd, Bath, IN 47010-9705 Ph: () - | Meagan Ellinger, PHARMD 2030 Hetrick Rd, Bath, IN 47010-9705 Ph: (765) 580-9118 |
News Archive
The largest candy-consumption night of the year is right around the corner. More than 80 percent of parents say their kids will participate in a Halloween celebration, and when asked about concerns related to Halloween, more than two-thirds of parents say they are worried about their children's teeth, according to a recent Ad Council survey.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.
W. L. Gore & Associates (Gore) today released the following statement from the Gore REDUCE Clinical Study Principal Investigators on behalf of the Gore REDUCE Clinical Study Steering Committee in response to the recent CLOSURE I results presentation.
The incorporation of sleep-friendly ingredients in food and drinks is expected to have future potential as it closely aligns with many consumers' want for a better night's rest through natural methods, according to GlobalData, a leading data and analytics company.
Before the therapeutic potential of using human tissue-derived mesenchymal stromal cells (MSC) to treat immune and degenerative diseases can be fully determined, the effects of freeze-thawing and intravenous delivery on MSC function must be understood.
› Verified 5 days ago